Epstein Secrets

catel-Lucent France Communication Officer and Executive Vice-President Jaime Caruana General Manager, Bank for International Settlements (BIS), Basel John Casey Vice-President International News and Programming CNBC United Kingdom Pete Cashmore Chief Executive Officer and Founder Mashable

f Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charles W. Ergen Chairman, President and

catel-Lucent France Communication Officer and Executive Vice-President Jaime Caruana General Manager, Bank for International Settlements (BIS), Basel John Casey Vice-President International News and Programming CNBC United Kingdom Pete Cashmore Chief Executive Officer and Founder Mashable

f Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charles W. Ergen Chairman, President and

Executive Vice-President. Colombia AngloGold Ashanti Ltd South Africa Jaime Caruana General Manager. Bank for International Settlements (BIS), Basel John Casey Vice-President. International News and CNBC United Kingdom Programming Marc N. Casper President and Chief Executive Officer Thermo

eller & Co. World Vision International Banco BTG Pactual The Financial Times Barclays UNI Global Union University of Miami Xinhua News Agency Novartis AG Bunge Limited Germany France Saudi Arabia USA United Kingdom Switzerland USA USA United Arab Emirates Mexico Saudi Arabia Switzerland U

r executive positions with Quantanova and Scotia Holdings, plc. Prior to that, Dr. Dow was head of Global Drug Development with Hoffman-La Roche in Basel, Switzerland and previously was with Syntex Corporation for over 10 years in various senior positions in drug development. Dr. Dow holds a B.Sc. in

, he was a private consultant from 2006 to 2007. Prior to that he served as President and CEO of Chiron Corporation from 2003 to its acquisition by Novartis AG in 2006. Prior to that he served in various executive capacities for GlaxoSmithKline plc (GSK) and its predecessor companies, culminating in his te

r executive positions with Quantanova and Scotia Holdings, plc. Prior to that, Dr. Dow was head of Global Drug Development with Hoffman-La Roche in Basel, Switzerland and previously was with Syntex Corporation for over 10 years in various senior positions in drug development. Dr. Dow holds a B.Sc. in

, he was a private consultant from 2006 to 2007. Prior to that he served as President and CEO of Chiron Corporation from 2003 to its acquisition by Novartis AG in 2006. Prior to that he served in various executive capacities for GlaxoSmithKline plc (GSK) and its predecessor companies, culminating in his te

r executive positions with Quantanova and Scotia Holdings, plc. Prior to that, Dr. Dow was head of Global Drug Development with Hoffman-La Roche in Basel, Switzerland and previously was with Syntex Corporation for over 10 years in various senior positions in drug development. Dr. Dow holds a B.Sc. in

, he was a private consultant from 2006 to 2007. Prior to that he served as President and CEO of Chiron Corporation from 2003 to its acquisition by Novartis AG in 2006. Prior to that he served in various executive capacities for GlaxoSmithKline plc (GSK) and its predecessor companies, culminating in his te

ecutive Chief Marketing, Strategy and Communication Officer and Executive Vice-President General Manager, Bank for International Settlements (BIS), Basel Vice-President International News and Programming Chief Executive Officer and Founder Chief Executive Officer Chief Executive Officer Chief Execut

. British Council Harvard Kennedy School IRSA Inversiones y Representaciones SA Airbus SAS Vestas Wind Systems A/S Evonik Industries AG Metabolix Novartis AG JPMorgan Chase & Co. DISH Network Empresa Periodistica El Mercurio SAP Intel Corporation Yale University Trade Union Advisory Committee to the